Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.4 USD | +0.10% | +0.08% | +57.47% |
05-01 | North American Morning Briefing : Traders Wait for -2- | DJ |
04-30 | Barclays Upgrades Deciphera Pharmaceuticals to Equalweight From Underweight, Price Target is $26 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.47% | 2.09B | |
+3.13% | 108B | |
+10.88% | 104B | |
+1.28% | 22.33B | |
-11.93% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.06% | 17.64B | |
+4.51% | 14.05B | |
+35.02% | 12.51B |
- Stock Market
- Equities
- DCPH Stock
- News Deciphera Pharmaceuticals, Inc.
- HC Wainwright Adjusts Deciphera Pharmaceuticals' Price Target to $30 From $25, Keeps Buy Rating